mortality/aging
• homozygous mutant mice die perinatally
|
Allele Symbol Allele Name Allele ID |
Kctd1Mhdahst014 Martin Hrabe de Angelis Hst014 MGI:5910041 |
||||||||||||
Summary |
2 genotypes
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• homozygous mutant mice die perinatally
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• increased daily urine calcium excretion at 28-32 weeks of age
|
• increased daily urine magnesium excretion at 28-32 weeks of age
|
• decreased urine osmolality at 28-32 weeks of age
|
• decreased urine pH at 28-32 weeks of age
|
• decreased albumin excretion at 28-32 weeks of age
|
• decreased uric acid excretion at 28-32 weeks of age
|
• kidney dysfunction and secondary effects thereof is the primary phenotype observed
• however, no gross histological alterations are observed in the kidneys
|
• slightly increased urinary volume at 28-32 weeks of age
• however, water intake is not significantly altered
|
• increased plasma creatinine levels at 17 weeks of age
|
• increased plasma urea levels at 6, 9 and 17 weeks of age in both sexes
|
• slightly increased glucose levels under fasting and fed conditions at 14 weeks of age
|
• increased plasma calcium levels in females at 17 weeks of age
|
• increased plasma potassium levels at 17 weeks of age
|
• increased plasma alpha-amylase activity level at 17 weeks of age
|
• at 17 weeks of age
|
• slightly decreased respiratory exchange ratios at 13 weeks of age under ad libitum feeding conditions
|
• increased daily urine calcium excretion at 28-32 weeks of age
|
• decreased plasma chloride levels at 17 weeks of age
|
• increased daily urine magnesium excretion at 28-32 weeks of age
|
• decreased urine osmolality at 28-32 weeks of age
|
• decreased urine pH at 28-32 weeks of age
|
• decreased albumin excretion at 28-32 weeks of age
|
• decreased uric acid excretion at 28-32 weeks of age
|
• decreased alkaline phosphatase activity at 17 weeks of age
|
• reduced red blood cell count at 17 weeks of age
|
• at 17 weeks of age
|
• at 17 weeks of age
|
• at 17 weeks of age
|
• at 17 weeks of age
|
• slight hypophagia at 13 weeks of age under ad libitum feeding conditions
|
• modified SHIRPA analysis revealed tremors in 6 of 15 heterozygous males (versus 0 of 15 in wild-type males) at 9 weeks of age
|
• reduced grip strength for 4 paws in heterozygous males (219 +/- 9 versus 260 +/- 20 in wild-type males) and heterozygous females (223 +/- 18 versus 236 +/- 22 in wild-type females)
|
• modified SHIRPA analysis revealed presence of trunk curl in 2 of 15 heterozygous males (versus 0 of 15 in wild-type males) and 8 of 15 heterozygous females (versus 2 of 15 in wild-type females) at 9 weeks of age
|
• modified SHIRPA analysis revealed tail dragging in 12 of 15 heterozygous males (versus 4 of 15 in wild-type males) and 6 of 15 heterozygous females (versus 2 of 15 in wild-type females) at 9 weeks of age
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/12/2024 MGI 6.24 |
|
|